Success in cancer treatment has resulted in at least half of patients diagnosed across the developed world in 2019 realistically being able to expect to be alive in 2029. Progress has not been uniform across all malignancies, with lung, pancreatic, and central nervous system tumours sadly lagging behind others. Urological cancers, in general, are at the other end of the spectrum, with 10-yr survival of >=50% for bladder and kidney cancers, >80% for prostate cancer, and approximately 98% for testicular tumours.